| For: | Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, Liva S, Nigro G, Miracolo A, Festi D, Colecchia A, Montagnani M, Roda E, Mazzella G. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. World J Gastroenterol 2003; 9(7): 1487-1490 [PMID: 12854147 DOI: 10.3748/wjg.v9.i7.1487] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/1487.htm |
| Number | Citing Articles |
| 1 |
D Devendra, G.S Eisenbarth. Interferon alpha—a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clinical Immunology 2004; 111(3) doi: 10.1016/j.clim.2004.01.008
|
| 2 |
Laura M Stinton, Robert P Myers, Carla S Coffin, Marvin J Fritzler. Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-50
|
| 3 |
Nikolaos K. Gatselis, Sarah P. Georgiadou, Nikolaos Tassopoulos, Kalliopi Zachou, Christos Liaskos, Angelos Hatzakis, Georgios N. Dalekos. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. World Journal of Gastroenterology 2005; 11(4): 482-487 doi: 10.3748/wjg.v11.i4.482
|
| 4 |
Giovanni Covini, Wendy C Carcamo, Elena Bredi, Carlos A von Mühlen, Massimo Colombo, Edward KL Chan. Cytoplasmic Rods and Rings Autoantibodies Developed during Pegylated Interferon and Ribavirin Therapy in Patients with Chronic Hepatitis C. Antiviral Therapy 2012; 17(5) doi: 10.3851/IMP1993
|
| 5 |
Jesper Brok, Martin Thyge Mellerup, Kim Krogsgaard, Christian Gluud. Glucocorticosteroids for viral hepatitis C. Cochrane Database of Systematic Reviews 2004; 2009(1) doi: 10.1002/14651858.CD002904.pub2
|
| 6 |
Francesca Lodato, Maria Rosa Tamé, Antonio Colecchia, Chiara Racchini, Francesco Azzaroli, Antonia D’Errico, Silvia Casanova, Antonio Pinna, Enrico Roda, Giuseppe Mazzella. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence. World Journal of Gastroenterology 2006; 12(26): 4253-4255 doi: 10.3748/wjg.v12.i26.4253
|
| 7 |
Laura M. Stinton, Chelsea Bentow, Michael Mahler, Gary L. Norman, Bertus Eksteen, Andrew L. Mason, Gilaad G. Kaplan, Bjorn Lindkvist, Gideon M. Hirschfield, Piotr Milkiewicz, Angela Cheung, Harry L. A. Janssen, Marvin J. Fritzler, Niklas K. Björkström. PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC). PLoS ONE 2014; 9(11) doi: 10.1371/journal.pone.0112877
|
| 8 |
S. John Calise, Nicola Bizzaro, Thuy Nguyen, Danila Bassetti, Brunetta Porcelli, Paolo Almi, Giuseppina Barberio, Giampaola Pesce, Minoru Satoh, Edward K. L. Chan. Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection. Autoimmunity Highlights 2016; 7(1) doi: 10.1007/s13317-016-0087-9
|
| 9 |
Travis Piester, Quin Y. Liu. Pediatric Gastrointestinal and Liver Disease. 2021; doi: 10.1016/B978-0-323-67293-1.00026-8
|
| 10 |
Corrado Betterle, Fabio Presotto. Terapia con interferoni e autoimmunità organo-specifica: quali rischi e come gestire il paziente. L'Endocrinologo 2010; 11(5) doi: 10.1007/BF03344741
|
| 11 |
Irfan Soykan, Mustafa Yakut, Onur Keskin. Hepatitis C virus antibody positivity may not be associated with hepatitis C infection in patients with autoimmune gastritis. European Journal of Gastroenterology & Hepatology 2013; 25(1) doi: 10.1097/MEG.0b013e3283595c75
|
| 12 |
Luís Jesuino de Oliveira Andrade, Ajax Mercês Atta, Maria Luiza Brito de Sousa Atta. Hepatite C e tireoide. 2021; doi: 10.7476/9786586213737.0004
|
| 13 |
Matthew Sochat, Daniela Hermelin, Daniel Chakos, Azam Farooqui, Jason Lunt, Ara Vartanyan, Nishant Poddar. When the diagnosis is difficult to digest: severe vitamin B12 deficiency secondary to pernicious anemia mimicking life-threatening thrombotic thrombocytopenic purpura. Journal of Hematopathology 2019; 12(1) doi: 10.1007/s12308-019-00340-4
|
| 14 |
S. John Calise, Edward K.L. Chan. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery. Autoimmunity Reviews 2020; 19(10) doi: 10.1016/j.autrev.2020.102643
|
| 15 |
Eva Zusinaite, Kaja Metsküla, Riina Salupere. Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia. World Journal of Gastroenterology 2005; 11(4): 488-491 doi: 10.3748/wjg.v11.i4.488
|
| 16 |
Richard Sallie. Replicative homeostasis II: Influence of polymerase fidelity on RNA virus quasispecies biology: Implications for immune recognition, viral autoimmunity and other "virus receptor" diseases. Virology Journal 2005; 2(1) doi: 10.1186/1743-422X-2-70
|
| 17 |
N. K. GATSELIS, S. P. GEORGIADOU, G. K. KOUKOULIS, N. TASSOPOULOS, K. ZACHOU, C. LIASKOS, A. HATZAKIS, G. N. DALEKOS. Clinical significance of organ‐ and non‐organ‐specific autoantibodies on the response to anti‐viral treatment of patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2006; 24(11-12) doi: 10.1111/j.1365-2036.2006.03165.x
|
| 18 |
F. LODATO, S. BERARDI, A. GRAMENZI, G. MAZZELLA, M. LENZI, M. C. MORELLI, M. R. TAME, F. PISCAGLIA, P. ANDREONE, G. BALLARDINI, M. BERNARDI, F. B. BIANCHI, M. BISELLI, L. BOLONDI, M. CESCON, A. COLECCHIA, A. D’ERRICO, M. DEL GAUDIO, G. ERCOLANI, G. L. GRAZI, W. GRIGIONI, S. LORENZINI, A. D. PINNA, M. RAVAIOLI, E. RODA, C. SAMA, M. VIVARELLI. Clinical trial: peg‐interferon alfa‐2b and ribavirin for the treatment of genotype‐1 hepatitis C recurrence after liver transplantation. Alimentary Pharmacology & Therapeutics 2008; 28(4) doi: 10.1111/j.1365-2036.2008.03761.x
|
| 19 |
Edward L. Lee, Mark Feldman. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; doi: 10.1016/B978-1-4160-6189-2.00051-2
|
| 20 |
Huy A. Tran, Glenn E.M. Reeves, Elizabeth A. Ianna, Nadine Leembruggen. Thyroid Function Outcomes after Pegylated Interferon-α and Ribavirin Therapy - For Chronic Hepatitis C. Endocrine Practice 2010; 16(6) doi: 10.4158/EP10036.OR
|
| 21 |
Taiba Zornitzki, Stephen Malnick, Lyudmila Lysyy, Hilla Knobler. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World Journal of Gastroenterology 2015; 21(1): 233-239 doi: 10.3748/wjg.v21.i1.233
|
| 22 |
Marilena Durazzo, Alberto Premoli, Cataldo Di Bisceglie, Angela Bertagna, Emanuela Fagà, Giampaolo Biroli, Chiara Manieri, Simona Bo, Gianfranco Pagano. Alterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection?. World Journal of Gastroenterology 2006; 12(19): 3073-3076 doi: 10.3748/wjg.v12.i19.3073
|
| 23 |
Rashmi Advani, Suryateja Devarakonda Rao, Quin Y. Liu. Pediatric Gastrointestinal and Liver Disease. 2026; doi: 10.1016/B978-0-443-11760-2.00026-4
|
| 24 |
Corrado Betterle, Fabio Presotto. HCV Infection and Cryoglobulinemia. 2012; doi: 10.1007/978-88-470-1705-4_5
|
| 25 |
Fatemeh Afsharzadeh, Farah Bokharaei-Salim, Maryam Esghaei, Seyed Hamidreza Monavari, Shahin Merat, Hossein Poustchi, Arghavan Haj-Sheykholeslami, Hossein Keyvani. The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection. Hepatitis Monthly 2016; 16(12) doi: 10.5812/hepatmon.42388
|
| 26 |
Raffaele Cozzolongo, Corrado Betterle, Paolo Fabris, Maria Paola Albergoni, Elsa Lanzilotta, Onofrio G. Manghisi. Onset of type 1 diabetes mellitus during peginterferon ??-2b plus ribavirin treatment for chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2006; 18(6) doi: 10.1097/00042737-200606000-00018
|
| 27 |
Zepeng Zhang, Tongtong Zhu, Lei Zhang, Yanchao Xing, Zhiqiang Yan, Qingsong Li. Critical influence of cytokines and immune cells in autoimmune gastritis. Autoimmunity 2023; 56(1) doi: 10.1080/08916934.2023.2174531
|